Thomas Hanke - Concepedia

Author

Thomas Hanke

Max Bergmann Zentrum für Biomaterialien ORCID

Also Known As

C. Carp, Crijns HJGM, Hanke Thomas, Hanke, Thomas, Hans-H. Sievers, J Takkenberg, T HANKE, T Hanke, T. Hanke, THOMAS HANKE

362

Publications

Citations

H-Index

162

Concepts

All Affiliations

Max Bergmann Zentrum für Biomaterialien Technische Universität Dresden Goethe University Frankfurt University of Würzburg Justus-Liebig-Universität Gießen

About

Thomas Hanke is an author at Max Bergmann Zentrum für Biomaterialien specializing in medicine, engineering, and tissue engineering.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	30	56	3.5K
2	Engineering	21	30	1.8K
3	Natural Sciences	10	10	484
4	Health Sciences	3	3	53
5	Public Health	1	1	15

Thomas Hanke

119

Publications

7.2K

Citations

H-Index

Page 1

	Year	Citations
Direct Assessment of MHC Class I Binding by Seven Ly49 Inhibitory NK Cell Receptors Thomas Hanke, Hisao Takizawa, Christopher W. McMahon, Immunity Autoimmune DiseaseMhc ClassMedicineImmunologyImmunologic Mechanism	1999	301
Quantitative, Wide-Spectrum Kinase Profiling in Live Cells for Assessing the Effect of Cellular ATP on Target Engagement James D. Vasta, Cesear Corona, Jennifer Wilkinson, Cell chemical biology Drug TargetWide-spectrum Kinase ProfilingKinase InhibitorsCytoskeletonCellular Physiology	2017	281
Viral Infections Induce Abundant Numbers of Senescent CD8 T Cells David Voehringer, Claudine Blaser, Pierre Brawand, The Journal of Immunology	2001	238
First evidence of chitin as a component of the skeletal fibers of marine sponges. Part I. Verongidae (demospongia: Porifera) Hermann Ehrlich, Manuel Maldonado, Klaus‐Dieter Spindler, Journal of Experimental Zoology Part B Molecular and Developmental Evolution EngineeringMolecular BiologyCytoskeletonAnatomySynapsida	2007	236
Enhancement of MHC class I-restricted peptide-specific T cell induction by a DNA prime/MVA boost vaccination regime Thomas Hanke Vaccine VaccinationImmunologyImmunodominanceTherapeutic VaccineAntigen Processing	1998	222
Selective targeting of regulatory T cells with CD28 superagonists allows effective therapy of experimental autoimmune encephalomyelitis Niklas Beyersdorf, Stefanie Gaupp, Karen Balbach, The Journal of Experimental Medicine	2005	203
Crystal structure of a soluble CD28-Fab complex Edward J. Evans, Robert Esnouf, Raquel Manso-Sancho, Nature Immunology Crystal StructureStructure ElucidationMolecular BiologyCrystallographyCrystal Structure Design	2005	173
CD28‐mediated induction of proliferation in resting T cells <i>in vitro</i> and <i>in vivo</i> without engagement of the T cell receptor: Evidence for functionally distinct forms of CD28 Michael Tacke, Gabriele Hanke, Thomas Hanke, European Journal of Immunology	1997	162
Cutting Edge: Identification of E-Cadherin as a Ligand for the Murine Killer Cell Lectin-Like Receptor G1 Carsten Gründemann, Monika Bauer, Oliver Schweier, The Journal of Immunology T-regulatory CellImmunologyNk CellsCell DeathImmunologic Mechanism	2006	157
First evidence of the presence of chitin in skeletons of marine sponges. Part II. Glass sponges (Hexactinellida: Porifera) Hermann Ehrlich, Manfred Krautter, Thomas Hanke, Journal of Experimental Zoology Part B Molecular and Developmental Evolution BiologyTissue EngineeringBiocompatible MaterialMarine SpongesEngineering	2007	151

Page 1